EHC
Encompass Health Corporation · Healthcare · Medical - Care Facilities
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.1% ·
aandelenstroom +3.2% ·
netto nieuwe posities +4.2%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 22.59K | $2.77M | n/a | n/a |
| Q2 2026 | 133 | -3 | 69.47M | $7.01B | +2 | −4 |
| Q1 2026 | 138 | +3 | 68.76M | $6.68B | +9 | −7 |
| Q4 2025 | 136 | -2 | 75.50M | $8.01B | +1 | −2 |
| Q3 2025 | 24 | +2 | 41.27M | $5.24B | +2 | −1 |
| Q2 2025 | 20 | +2 | 37.20M | $4.56B | +2 | n/a |
| Q1 2025 | 15 | 0 | 14.75M | $1.49B | n/a | n/a |
| Q4 2024 | 15 | 0 | 14.46M | $1.34B | +1 | −1 |
| Q3 2024 | 14 | +3 | 13.62M | $1.32B | +3 | n/a |
| Q2 2024 | 11 | n/a | 14.78M | $1.27B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 10.24M | -1.4% | $1.30B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 9.88M | 0.0% | $1.25B | 0.0% | ▲ Add | 2 | SEC ↗ ×19 |
| 3 | T. Rowe Price ✦ | 3.86M | +174.0% | $489.94M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (passief) | 3.08M | -0.8% | $391.41M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | JPMorgan Chase ✦ | 2.82M | n/a | $358.28M | 0.0% | n/c | 1 | SEC ↗ ×24 |
| 6 | Wellington Management ✦ | 2.78M | -21.1% | $353.29M | 0.1% | ▼ Trim | 6 | SEC ↗ ×7 |
| 7 | Geode Capital Management ✦ (passief) | 1.81M | +2.0% | $229.73M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 1.22M | +140.0% | $155.43M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 1.07M | +3.4% | $135.58M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 1.05M | -38.0% | $133.70M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 11 | Morgan Stanley ✦ | 788.21K | n/a | $100.12M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 12 | AQR Capital Management ✦ | 645.28K | +47.5% | $81.70M | 0.1% | ▲ Add | 6 | SEC ↗ ×5 |
| 13 | Two Sigma Investments ✦ | 505.64K | +0.3% | $64.23M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 14 | Goldman Sachs Group ✦ | 332.66K | n/a | $42.25M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 15 | Citadel Advisors ✦ | 311.65K | -68.2% | $39.59M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Adage Capital Partners ✦ | 284.17K | +4.2% | $36.10M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 17 | Glenview Capital ✦ | 167.64K | Nieuw | $21.29M | 0.5% | New | 1 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 144.39K | +135.9% | $18.34M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 86.22K | -69.5% | $10.95M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 20 | Renaissance Technologies ✦ | 71.00K | +35.5% | $9.02M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 62.72K | -60.9% | $7.97M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 57.80K | +1671.3% | $7.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 4.77K | -0.5% | $606,139 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Point72 Asset Management ✦ | 420 | Nieuw | $53,348 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Glenview Capital | $21.29M | 0.5% |
| Point72 Asset Management | $53,348 | 0.0% |
Verlaten
| Norges Bank | $139.54M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 577 houders, 95.06M aandelen, $8.15B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 4.86K aand · $588,255
Officer · 5.21K aand · $630,166
Officer · 18.87K aand · $2.37M
Officer, Director · 1.58K aand · $199,049
Officer · 8.91K aand · $1.12M
Officer, Director · 171.57K aand · $21.53M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie